GAMMA Investing’s Regencell Bioscience RGC Stock Holding History

GAMMA Investing’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8	Closed	-$203	–	4213
2026 Q1	$203	Buy	+8	New	+$226	﹤0.01%	4056

Other funds holding RGC

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

GAMMA Investing's RGC Position: Q2 2026 in Review

GAMMA Investing sold out of Regencell Bioscience (RGC) in Q2 2026, closing a stake of 8 shares — an estimated $203 sold.

GAMMA Investing first reported a position in RGC in Q1 2026 and held it in 1 quarter. The position peaked at $203 in Q1 2026. 1 fund tracked by Wall St. Rank holds RGC as of Q2 2026.

GAMMA Investing reported no remaining Regencell Bioscience position as of Q2 2026 after selling out during the quarter.
GAMMA Investing sold 8 Regencell Bioscience shares in Q2 2026, an estimated $203.
GAMMA Investing first reported a position in Regencell Bioscience in Q1 2026 and held it in 1 quarter.
GAMMA Investing's Regencell Bioscience position peaked at $203 in Q1 2026.
1 fund tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.